Hirsch Warren 4
4 · ProPhase Labs, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Hirsch Warren
Director
Transactions
- Award
Option (right to buy)
2025-02-14+100,000→ 100,000 totalExercise: $0.60Exp: 2032-02-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date.